$0.57
+0.00 (+0.21%)
Open$0.57
Previous Close$0.57
Day High$0.59
Day Low$0.56
52W High$2.56
52W Low$0.47
Volume—
Avg Volume213.7K
Market Cap5.94M
P/E Ratio—
EPS$-0.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,825.0% upside
Current
$0.57
$0.57
Target
$27.92
$27.92
$15.39
$27.92 avg
$30.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 49.97M | 61.29M | 3.60M |
| Net Income | -5,315,303 | -5,866,780 | 438.1K |
| Profit Margin | -10.6% | -10.1% | 12.2% |
| EBITDA | -2,699,554 | -3,145,175 | 810.0K |
| Free Cash Flow | — | — | 302.1K |
| Rev Growth | -18.5% | -18.5% | +16.0% |
| Debt/Equity | — | — | 0.63 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |